These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 3141344)

  • 21. The pharmacokinetics and therapeutic efficacy of fleroxacin and pefloxacin in a rat abscess model.
    Leibovitz E; Keren G; Shabtai M; Barzilai A; Rubinstein E
    J Antimicrob Chemother; 1989 Sep; 24(3):375-85. PubMed ID: 2509411
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Single- and multiple-dose pharmacokinetics of fleroxacin, a trifluorinated quinolone, in humans.
    Weidekamm E; Portmann R; Suter K; Partos C; Dell D; Lücker PW
    Antimicrob Agents Chemother; 1987 Dec; 31(12):1909-14. PubMed ID: 3125788
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Concentrations of temafloxacin in serum and bronchial mucosa.
    Baldwin DR; Wilkinson L; Andrews JM; Ashby JP; Wise R; Honeybourne D
    Eur J Clin Microbiol Infect Dis; 1990 Jun; 9(6):432-4. PubMed ID: 2387297
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Single-dose pharmacokinetic study of ciprofloxacin and fleroxacin in healthy adult Nigerian volunteers.
    Chukwuani CM; Coker HA; Oduola AM; Ifudu ND; Sowunmi A
    Chemotherapy; 1998; 44(6):369-76. PubMed ID: 9755295
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Penetration of ciprofloxacin into bronchial secretions from mechanically ventilated patients with nosocomial bronchopneumonia.
    Saux P; Martin C; Mallet MN; Papazian L; Bruguerolle B; De Micco P; Gouin F
    Antimicrob Agents Chemother; 1994 Apr; 38(4):901-4. PubMed ID: 8031070
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparative oral pharmacokinetics of fleroxacin and pefloxacin.
    De Lepeleire I; Van Hecken A; Verbesselt R; Tjandra-Maga TB; De Schepper PJ
    J Antimicrob Chemother; 1988 Aug; 22(2):197-202. PubMed ID: 3141343
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Liquid-chromatographic determination of fleroxacin in serum and urine.
    Awni WM; Maloney JA; Heim-Duthoy KL
    Clin Chem; 1988 Nov; 34(11):2330-2. PubMed ID: 3141086
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In-vitro activity of fleroxacin against isolates causing complicated urinary tract infections and concentrations in seminal and prostatic fluid and in prostatic adenoma tissue.
    Naber KG; Sörgel F; Kees F; Schumacher H; Metz R; Grobecker H
    J Antimicrob Chemother; 1988 Oct; 22 Suppl D():199-207. PubMed ID: 2462556
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Steady-state pharmacokinetics of fleroxacin in patients with skin and skin structure infections.
    Heim-Duthoy K; Peltier G; Awni W
    Antimicrob Agents Chemother; 1990 May; 34(5):922-3. PubMed ID: 2113797
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Penetration of piperacillin into bronchial mucosa and sputum.
    Marlin GE; Burgess KR; Burgoyne J; Funnell GR; Guinness MD
    Thorax; 1981 Oct; 36(10):774-80. PubMed ID: 6460337
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacokinetics and biliary concentrations of fleroxacin in cholecystectomized patients.
    Hayton WL; Vlahov V; Bacracheva N; Viachki I; Portmann R; Muirhead G; Stoeckel K; Weidekamm E
    Antimicrob Agents Chemother; 1990 Dec; 34(12):2375-80. PubMed ID: 2128442
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The distribution of ciprofloxacin and its metabolites in human plasma, pulmonary and bronchial tissues.
    Bacracheva N; Scholl H; Gerova Z; Chervenakov P; Dobrev P; Vlahov V
    Int J Clin Pharmacol Ther Toxicol; 1991 Sep; 29(9):352-6. PubMed ID: 1937996
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Concentration of meropenem in serum and in bronchial secretions in patients undergoing fibreoptic bronchoscopy.
    Bergogne-Bérézin E; Muller-Serieys C; Aubier M; Dombret MC
    Eur J Clin Pharmacol; 1994; 46(1):87-8. PubMed ID: 8005193
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Penetration of enoxacin into human bronchial mucosa.
    Marlin GE; Braude PD; Whelan AJ; Somogyi AA
    Am Rev Respir Dis; 1986 Dec; 134(6):1209-12. PubMed ID: 3466562
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Influence of sex on the pharmacokinetic interaction of fleroxacin and ciprofloxacin with caffeine.
    Kim MK; Nightingale C; Nicolau D
    Clin Pharmacokinet; 2003; 42(11):985-96. PubMed ID: 12908854
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Penetration of cefaclor into bronchial mucosa.
    Marlin GE; Nicholls AJ; Funnell GR; Bradbury R
    Thorax; 1984 Nov; 39(11):813-7. PubMed ID: 6505987
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High-performance liquid chromatographic assay and erythrocyte partitioning of fleroxacin, a new fluoroquinolone antibiotic.
    Brunt E; Limberg J; Derendorf H
    J Pharm Biomed Anal; 1990; 8(1):67-71. PubMed ID: 2129330
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Disposition of fleroxacin, a new trifluoroquinolone, and its metabolites. Pharmacokinetics in renal failure and influence of haemodialysis.
    Singlas E; Leroy A; Sultan E; Godin M; Moulin B; Taburet AM; Dhib M; Fillastre JP
    Clin Pharmacokinet; 1990 Jul; 19(1):67-79. PubMed ID: 2116256
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Therapeutic effect of fleroxacin against experimental pneumonia in mice.
    Niki Y; Watanabe M; Tasaka Y; Umeki S; Soejima R
    J Antimicrob Chemother; 1988 Oct; 22 Suppl D():129-31. PubMed ID: 3144531
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Developmental toxicity of fleroxacin and comparative pharmacokinetics of four fluoroquinolones in the cynomolgus macaque (Macaca fascicularis).
    Hummler H; Richter WF; Hendrickx AG
    Toxicol Appl Pharmacol; 1993 Sep; 122(1):34-45. PubMed ID: 8397453
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.